Bio Tech Pills - Search News

News

FDA Appoints Biotech Exec

Biotech exec George Tidmarsh picked as FDA's chief drug regulator

The U.S. Food and Drug Administration named ex-biotech exec George Tidmarsh as its chief drug regulator. FDA Commissioner Marty Makary called Tidmarsh an "accomplished physician-scientist and leader."

· 23h

FDA appoints biotech veteran George Tidmarsh to lead drug evaluation division

· 23h

Former biotech executive appointed to lead FDA drug review office

BioPharma Dive4m

Replimune drug rejected by FDA; Omega raises $647M biotech fund

Analysts questioned whether the complete response letter Replimune received was evidence of changing approval standards at ...

16h

Ticker: Americans putting money in investment income; FDA names former pharmaceutical company executive to oversee US drug program

Ticker: Americans putting money in investment income; FDA names former pharmaceutical company executive to oversee US drug ...

24m

Makary ally named to key FDA drug post

Dr. George Tidmarsh, a Stanford pediatrics adjunct professor and former pharmaceutical executive, is FDA Commissioner Marty Makary’s pick to be the nation’s top drug regulator.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results